Regardless, LRIG1 still exerts tumor-suppressive functions in CRPC (Fig. 5g, h), suggesting that in treatment-failed tumors, LRIG1, positively regulated by AR and, possibly, by stemness factors, still functions to curb tumor development driven by these oncogenic factors. The gene discussed is LRIG1; the disease is neoplasm.